Navigation Links
Lilly Announces Termination of AIR Insulin Program
Date:3/7/2008

des answers - through medicines and information - for some of the world's most urgent medical needs. Additional information about Lilly is available at http://www.lilly.com. P-LLY

This press release contains forward-looking statements that are based on management's current expectations, but actual results may differ materially due to various factors. There are significant risks and uncertainties in pharmaceutical research and development. There can be no guarantees with respect to pipeline products that the products will receive the necessary clinical and manufacturing regulatory approvals or that they will prove to be commercially successful. The company's results may also be affected by such factors as competitive developments affecting current products; rate of sales growth of recently launched products; the timing of anticipated regulatory approvals and launches of new products; regulatory actions regarding currently marketed products; other regulatory developments and government investigations; patent disputes and other litigation involving current and future products; the impact of governmental actions regarding pricing, importation, and reimbursement for pharmaceuticals; changes in tax law; asset impairments and restructuring charges; acquisitions and business development transactions; and the impact of exchange rates. For additional information about the factors that affect the company's business, please see the company's latest Form 10-K filed February 2008. The company undertakes no duty to update forward-looking statements.

(Logo: http://www.newscom.com/cgi-bin/prnh/20031219/LLYLOGO )


'/>"/>
SOURCE Eli Lilly and Company
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Emisphere Technologies, Inc. and Eli Lilly and Company Settle Ongoing Litigation
2. Lilly Declares Fourth-Quarter Dividend
3. Robert Conley, M.D. to Join Lilly; Will assume a neuroscience leadership role as a Distinguished Lilly Scholar
4. Lilly and BioMS Medical Announce Global Licensing and Development Agreement
5. Daiichi Sankyo, Lilly Submit New Drug Application for Investigational Antiplatelet Drug, Prasugrel, with U.S. Food and Drug Administration
6. In response to a New England Journal of Medicine article published yesterday and subsequent media coverage, Eli Lilly and Company issued the following statement:
7. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
8. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
9. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
10. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
11. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009)..., ,, BETHESDA, Md., Nov. 19 /PRNewswire-Fir...an innovator in biotechnology for diabetes therapy...lting services to food, supplement, biotechnology ...losed the previously reported $6.3 million registe... 2,760,870 shares of its common stock and warrants...
(Date:11/19/2009)..., MALVERN, Pa. and WALTHAM, Mass., Nov. 19 /PRNe...ecision Resources find that the leading driver of ...rope is broad-spectrum activity against gram-posit...y of organisms that can cause nosocomial pneumonia...ok primarily for agents that provide appropriate c...
(Date:11/19/2009)... Top LASIK surgeons and recognized r...rusted LASIK Surgeons made brought their fellow su...sion correction surgery, cataract surgery, and oph...erican Academy of Ophthalmology (AAO) annual meeti...trom, Dr. Shachar Tauber, Dr. David Huang, MD, Dr....
(Date:11/19/2009)..., VIENNA, Austria, November 19 /PRNewswire/ ...rogram on one product candidate at an unexpectedly... AD02 is planned to enter into,Phase II clinical t...mmediately follows the completion of two Phase I t...ny based its fast decision on the first interim,an...
Breaking Biology Technology:Spherix Announces the Closing of $6.3 Million Registered Direct Offering 2Spherix Announces the Closing of $6.3 Million Registered Direct Offering 3Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 2Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 3Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 2Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 3Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 4Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 5Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 6Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 7Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 8Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 9AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing 2AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing 3
...l amounts are in U.S. dollars, QUEBEC CITY, Nov. ...(NASDAQ: AEZS , TSX: AEZ), a global biopharmaceut..., today reported financial and operating results,f...Third Quarter 2008 Highlights, - Appointment on S...dent and CEO of AEterna Zentaris, replacing Jue...
... Driven by the human genom...tric diseases, neurosciences, and drug development...c therapeutics), world market for biotechnology re.... The shift towards proteomics from genomics in th...to benefit protein related product markets in the ...
...LBOURNE, Australia, Nov. 12 Melbourne-based Starf...e of its Starfish Technology,Fund II at $185 milli...tralia. The fund will invest in ICT, Life Sciences...ndraising is an endorsement of Starfish Ventures,a... the development of,innovative companies that, wit...
Other Biology Technology:AEterna Zentaris Reports Third Quarter 2008 Financial and Operating Results 2AEterna Zentaris Reports Third Quarter 2008 Financial and Operating Results 3AEterna Zentaris Reports Third Quarter 2008 Financial and Operating Results 4AEterna Zentaris Reports Third Quarter 2008 Financial and Operating Results 5AEterna Zentaris Reports Third Quarter 2008 Financial and Operating Results 6AEterna Zentaris Reports Third Quarter 2008 Financial and Operating Results 7AEterna Zentaris Reports Third Quarter 2008 Financial and Operating Results 8AEterna Zentaris Reports Third Quarter 2008 Financial and Operating Results 9World Market for Biotechnology Reagents to Reach $32.5 Billion by 2012, According to New Report by Global Industry Analysts, Inc. 2World Market for Biotechnology Reagents to Reach $32.5 Billion by 2012, According to New Report by Global Industry Analysts, Inc. 3Starfish Ventures Closes Australia's Largest Venture Capital Fund With $185 Million Tech Fund 2
(Date:11/19/2009)...ago, at the end of the last ice age, North America...h iconic creatures as mammoths, mastodons, camels,...eir precipitous slide to extinction. , And when ...iversity of large animals equaled or surpassed Afr...an entirely novel ecosystem emerged as broadleaved...
(Date:11/19/2009)... are revealing the genetic instructions inside cor...ze, has one of the most complex sequences of DNA e... genomicist David Schwartz, who was one of more th...nce . , "The maize genome is a true maze full o...ed would-be sequencers for years," says Schwartz. ...
(Date:11/19/2009)... more than 2: The offspring of two inbred strains ...acterizing the gene-level variability that leads t...gor, could boost our ability to custom-tailor crop...t for human consumption or high glucose content fo...ased DNA sequence of the common corn strain B73, U...
Breaking Biology News(10 mins):After mastodons and mammoths, a transformed landscape 2After mastodons and mammoths, a transformed landscape 3Sweet corn story begins in UW-Madison lab 2Sweet corn story begins in UW-Madison lab 3U of M plant scientist uncovers clues to yield-boosting quirks of corn genome 2New Nutrisystem Works 28TM 29 Offers Corporate America New Weapon in the Fight Against Obesity 48167 1New Nutrisystem Works 28TM 29 Offers Corporate America New Weapon in the Fight Against Obesity 48167 2New Nutrisystem Works 28TM 29 Offers Corporate America New Weapon in the Fight Against Obesity 48167 3New Nutrisystem Works 28TM 29 Offers Corporate America New Weapon in the Fight Against Obesity 48167 4Abbotts TRILIPIX 28R 29 28Fenofibric Acid 29 in Combination With Rosuvastatin Calcium Helps Patients With Mixed Dyslipidemia and Type 2 Diabetes Meet 48164 1Abbotts TRILIPIX 28R 29 28Fenofibric Acid 29 in Combination With Rosuvastatin Calcium Helps Patients With Mixed Dyslipidemia and Type 2 Diabetes Meet 48164 2Abbotts TRILIPIX 28R 29 28Fenofibric Acid 29 in Combination With Rosuvastatin Calcium Helps Patients With Mixed Dyslipidemia and Type 2 Diabetes Meet 48164 3Abbotts TRILIPIX 28R 29 28Fenofibric Acid 29 in Combination With Rosuvastatin Calcium Helps Patients With Mixed Dyslipidemia and Type 2 Diabetes Meet 48164 4Cadient Group Brings Home the Gold and Two Bronze Aster Awards 12521 1Cadient Group Brings Home the Gold and Two Bronze Aster Awards 12521 2
...cientists at the University of Chicago and the Nat...., have produced new evidence to finally resolve t...of the weirdest organisms that ever lived. , Their... a fungus, the scientists report in the May issue ...ical Society of America. Called Prototaxites (pron...
...esearchers at the Johns Hopkins School of Medicine...expressing a human light receptor in addition to t... the brain can adapt far more rapidly to new senso...earing March 23 in Science, also suggests that whe... of photoreceptor more than 40 million years ago, ...
...esearchers from the Schulich School of Medicine &a... , working with a group from Edinburgh, have disco...Burkholderia cenocepacia. These investigators, und...t of Microbiology and Immunology, have had their r...of Bacteriology, and highlighted in Nature Reviews...
Other Biology News:Prehistoric mystery organism verified as giant fungus 2Prehistoric mystery organism verified as giant fungus 3Prehistoric mystery organism verified as giant fungus 4Making mice with enhanced color vision 2Making mice with enhanced color vision 3Key found to kill cystic fibrosis superbug 2
Xylene cyanol FF, CI 43535 from Research Organics, Inc.
...e MasterPure™ Plant Leaf DNA Purification Kit...resh plant leaf tissue. The protocol can be comple...obtain larger amounts of DNA. The purified DNA can...ion, and Southern blotting. The MasterPure Kit was...
Acridine orange, hemizinc salt from Research Organics, Inc.
Acridine orange 10-nonyl bromide from AnaSpec
Biology Products: